Literature DB >> 24022629

[Useful tools for documenting urticaria].

P Staubach1, A Groffik.   

Abstract

Urticaria is one of the most common inflammatory skin diseases. Many patients suffer for many years of the subtypes of urticaria. Because of their symptoms, urticaria patients have a very low quality of life and are subject to comorbidities. A structured approach with validated evaluation tools helps (1) to diagnose the respective subtype of the disease, (2) to define the disease activity and (3) to analyze the impact on quality of life. By virtue of this, it is possible to adequately diagnose and manage urticaria patients without major investment of time or manpower. Tools to measure disease intensity (urticaria activity score, angioedema activity score) and questionnaires for quality of life in the cases of chronic urticaria and angioedema have been developed. Suspected diagnoses of comorbidity such as depression or anxiety can be confirmed by the appropriate questionnaire (Hamilton Anxiety Depression Scale [HADS]). In addition diagnostic instruments are helpful to define the intensity of the disease, especially in cases of inducible urticaria. All these forms, scores and questionnaires are easy to learn and employ in daily practice.

Entities:  

Mesh:

Year:  2013        PMID: 24022629     DOI: 10.1007/s00105-013-2569-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  14 in total

1.  Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment.

Authors:  Karsten Weller; Martin K Church; Dimitrios Kalogeromitros; Karoline Krause; Markus Magerl; Martin Metz; Dina Pisarevskaja; Frank Siebenhaar; Marcus Maurer
Journal:  Arch Dermatol       Date:  2011-10

2.  Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria.

Authors:  Frank Siebenhaar; Petra Staubach; Martin Metz; Markus Magerl; Jürgen Jung; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

Review 3.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Authors:  C Herrmann
Journal:  J Psychosom Res       Date:  1997-01       Impact factor: 3.006

4.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

5.  High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria.

Authors:  Petra Staubach; Markus Dechene; Martin Metz; Markus Magerl; Frank Siebenhaar; Karsten Weller; Peter Zezula; Annegret Eckhardt-Henn; Marcus Maurer
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

6.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

7.  EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.

Authors:  T Zuberbier; R Asero; C Bindslev-Jensen; G Walter Canonica; M K Church; A M Giménez-Arnau; C E H Grattan; A Kapp; M Maurer; H F Merk; B Rogala; S Saini; M Sánchez-Borges; P Schmid-Grendelmeier; H Schünemann; P Staubach; G A Vena; B Wedi
Journal:  Allergy       Date:  2009-10       Impact factor: 13.146

8.  Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria.

Authors:  A Młynek; M Magerl; F Siebenhaar; K Weller; R Vieira Dos Santos; T Zuberbier; A Zalewska-Janowska; M Maurer
Journal:  Br J Dermatol       Date:  2009-09-28       Impact factor: 9.302

9.  The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings.

Authors:  A Młynek; M Magerl; M Hanna; S Lhachimi; I Baiardini; G W Canonica; Z Brzoza; A Kasperska-Zajac; B Rogala; A Zalewska-Janowska; T Zuberbier; M Maurer
Journal:  Allergy       Date:  2009-06       Impact factor: 13.146

10.  How to assess disease activity in patients with chronic urticaria?

Authors:  A Młynek; A Zalewska-Janowska; P Martus; P Staubach; T Zuberbier; M Maurer
Journal:  Allergy       Date:  2008-06       Impact factor: 13.146

View more
  1 in total

Review 1.  [Age-specific aspects in the treatment of angioedema patients].

Authors:  P Staubach
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.